291 related articles for article (PubMed ID: 16619231)
1. Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients.
Slichter SJ
J Clin Apher; 2006 Apr; 21(1):78-84. PubMed ID: 16619231
[TBL] [Abstract][Full Text] [Related]
2. Dose of prophylactic platelet transfusions and prevention of hemorrhage.
Slichter SJ; Kaufman RM; Assmann SF; McCullough J; Triulzi DJ; Strauss RG; Gernsheimer TB; Ness PM; Brecher ME; Josephson CD; Konkle BA; Woodson RD; Ortel TL; Hillyer CD; Skerrett DL; McCrae KR; Sloan SR; Uhl L; George JN; Aquino VM; Manno CS; McFarland JG; Hess JR; Leissinger C; Granger S
N Engl J Med; 2010 Feb; 362(7):600-13. PubMed ID: 20164484
[TBL] [Abstract][Full Text] [Related]
3. The platelet-refractory bone marrow transplant patient: prophylaxis and treatment of bleeding.
Benson K; Fields K; Hiemenz J; Zorsky P; Ballester O; Perkins J; Elfenbein G
Semin Oncol; 1993 Oct; 20(5 Suppl 6):102-9. PubMed ID: 8211211
[TBL] [Abstract][Full Text] [Related]
4. Use of platelets in transfusion medicine.
Brubaker DB
J Am Osteopath Assoc; 1989 Dec; 89(12):1553-9. PubMed ID: 2621122
[TBL] [Abstract][Full Text] [Related]
5. [Transfusion of platelet concentrates].
Rieux C; Lee K; Lavaud A; Bierling P
Ann Med Interne (Paris); 1999 Dec; 150(8):631-41. PubMed ID: 10686645
[TBL] [Abstract][Full Text] [Related]
6. Determination of bleeding risk in thrombocytopenic patients with platelet transfusion therapy.
Kretschmer V; Huss B; Weber S; Bewarder S; Schulzki T; Köppler H; Heimanns J
Beitr Infusionsther Transfusionsmed; 1994; 32():434-6. PubMed ID: 9422122
[TBL] [Abstract][Full Text] [Related]
7. Platelet transfusion. Current techniques, remaining problems, and future prospects.
Herman JH; Kamel HT
Am J Pediatr Hematol Oncol; 1987; 9(3):272-86. PubMed ID: 3314551
[TBL] [Abstract][Full Text] [Related]
8. A contribution to the indications for platelet transfusion and determination of its therapeutic efficacy.
Kretschmer V; Huss B; Weber S; Bewarder S; Schulzki T; Köppler H; Heimanns J
Transfus Sci; 1994 Dec; 15(4):361-9. PubMed ID: 10155555
[TBL] [Abstract][Full Text] [Related]
9. Calculated platelet dose: Is it useful in clinical practice?
Askari S; Weik PR; Crosson J
J Clin Apher; 2002; 17(2):103-5. PubMed ID: 12210715
[TBL] [Abstract][Full Text] [Related]
10. Platelet dosing.
Schlossberg HR; Herman JH
Transfus Apher Sci; 2003 Jun; 28(3):221-6. PubMed ID: 12725947
[TBL] [Abstract][Full Text] [Related]
11. [Transfusion-refractory thrombocytopenia during chemotherapy: pathogenesis, frequency and treatment].
Helleberg C; Taaning EB; Johnsen HE
Ugeskr Laeger; 1995 Sep; 157(37):5082-6. PubMed ID: 7502374
[TBL] [Abstract][Full Text] [Related]
12. Platelet membrane vesicles reduced microvascular bleeding times in thrombocytopenic rabbits.
McGill M; Fugman DA; Vittorio N; Darrow C
J Lab Clin Med; 1987 Feb; 109(2):127-33. PubMed ID: 3805864
[TBL] [Abstract][Full Text] [Related]
13. Clinical perspectives of platelet transfusions: defining the optimal dose.
Strauss RG
J Clin Apher; 1995; 10(3):124-7. PubMed ID: 8582893
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of platelet transfusions in thrombocytopenic patients: methods and interpretation.
Kahn RA
Vox Sang; 1981; 40 Suppl 1():87-97. PubMed ID: 7293125
[No Abstract] [Full Text] [Related]
15. What is the proper threshold for platelet transfusion in patients with chemotherapy-induced thrombocytopenia?
Benjamin RJ; Anderson KC
Crit Rev Oncol Hematol; 2002 May; 42(2):163-71. PubMed ID: 12007974
[TBL] [Abstract][Full Text] [Related]
16. Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia.
Wandt H; Frank M; Ehninger G; Schneider C; Brack N; Daoud A; Fackler-Schwalbe I; Fischer J; Gäckle R; Geer T; Harms P; Löffler B; Ohl S; Otremba B; Raab M; Schönrock-Nabulsi P; Strobel G; Winter R; Link H
Blood; 1998 May; 91(10):3601-6. PubMed ID: 9572994
[TBL] [Abstract][Full Text] [Related]
17. Comparative clinical studies of platelet concentrates: effects on clinical outcome and the use of healthcare resources. NBS Platelet Study Group.
Pamphilon DH
Transfus Sci; 1996 Sep; 17(3):343-6. PubMed ID: 10163540
[TBL] [Abstract][Full Text] [Related]
18. Platelet transfusion and alternatives to transfusion in patients with malignancy.
Vaickus L; Breitmeyer JB; Schlossman RL; Anderson KC
Stem Cells; 1995 Nov; 13(6):588-96. PubMed ID: 8590860
[TBL] [Abstract][Full Text] [Related]
19. Platelet transfusions in adult thrombocytopenic ICU patients: Protocol for a sub-study of the PLOT-ICU cohort.
Anthon CT; Pène F; Perner A; Azoulay E; Puxty K; Van De Louw A; Chawla S; Castro P; Povoa P; Coelho L; Metaxa V; Kochanek M; Liebregts T; Kander T; Sivula M; Møller MH; Russell L
Acta Anaesthesiol Scand; 2024 Mar; 68(3):434-440. PubMed ID: 38115558
[TBL] [Abstract][Full Text] [Related]
20. Effects of in vitro adult platelet transfusions on neonatal hemostasis.
Ferrer-Marin F; Chavda C; Lampa M; Michelson AD; Frelinger AL; Sola-Visner M
J Thromb Haemost; 2011 May; 9(5):1020-8. PubMed ID: 21320282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
